| Bioactivity | LCB 03-0110, a thienopyridine derivative, is a potent pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor. LCB 03-0110 suppresses scar formation by inhibiting fibroblast and macrophage activation[1]. |
| Invitro | LCB 03-0110 抑制转化生长因子 β1 和 I 型胶原诱导的原代真皮成纤维细胞的增殖和迁移[1]。 |
| In Vivo | LCB 03-0110 可抑制愈合伤口中肌成纤维细胞和巨噬细胞的积累,并减少兔耳伤口闭合后肥厚性疤痕的形成[1]。 |
| Name | LCB 03-0110 |
| CAS | 1228102-01-9 |
| Formula | C24H23N3O2S |
| Molar Mass | 417.52 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Sun X, et, al. LCB 03-0110, a novel pan-discoidin domain receptor/c-Src family tyrosine kinase inhibitor, suppresses scar formation by inhibiting fibroblast and macrophage activation. J Pharmacol Exp Ther. 2012 Mar;340(3):510-9. |